Head-to-Head

GRAIL, Inc. Common Stock vs. Exagen Inc. Common Stock

GRAL

GRAIL, Inc. Common Stock

$128.08 +5.47%

VS XGN

Exagen Inc. Common Stock

$7.10 +22.20%

GRAIL, Inc. Common Stock and Exagen Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

GRALXGN
Market Cap $5.46 billion $140.75 million

GRAL leads on 1 of 1 size & scale factors.

Risk & Sentiment

GRALXGN
Short Interest 5.08% 0.02%

XGN leads on 1 of 1 risk & sentiment factors.

Dig deeper: GRAL overview, GRAL financials, XGN overview, XGN financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.